PROVIDER PROFILE · NPI 1962506055
Drew DylewskiM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,767
Unique beneficiaries
—
Total services
14,816
Distinct HCPCS
22
Medicare payment
$229K
Peer benchmark
Total Medicare services vs. 656 Urology providers in TX — top quintile (cohort median 2,730).
PRESCRIBING · PART D · 2024
Total Rx claims
3,244
Beneficiaries
—
Total drug cost
$391K
Distinct drugs
25
Brand share
12.5%
Top prescribed drugs
Tamsulosin Hcl1,223 claims
Finasteride1,017 claims
Oxybutynin Chloride150 claims
Solifenacin Succinate131 claims
Ciprofloxacin Hcl87 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$131
Payment records
4
By payment type
Food and Beverage$131
Top paying entities
Food and Beverage$131
REFERRAL NETWORK
Where Drew Dylewski's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX | 210 | 449 |
| Inform Diagnostics, Inc. Clinical Laboratory · Coppell, TX | 49 | 120 |
| TEXIENNE HOSPITAL SYSTEMS, L.P. | 36 | 145 |
| Matthew Hogan Urology · Tomball, TX | 27 | 68 |
| David Ellent Hematology-Oncology · Kingwood, TX | 23 | 90 |
| Liliana Woo Urology · Tomball, TX | 16 | 41 |
| TOMBALL TEXAS HOSPITAL COMPANY LLC | 16 | 29 |
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 11 | 37 |
| UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER | 11 | 28 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE